Processa Pharmaceuticals ...

NASDAQ: PCSA · Real-Time Price · USD
0.33
0.03 (9.78%)
At close: Jun 09, 2025, 3:59 PM

Processa Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.85M -11.12M -27.42M -11.43M
Depreciation & Amortization
782.00 222.00 788.5K 790.97K
Stock-Based Compensation
629.51K 1.06M 8.83M 3.41M
Other Working Capital
-681.67K 621.14K 434.96K -1.08M
Other Non-Cash Items
87.18K 1.39M 7.66M 220.61K
Deferred Income Tax
n/a n/a n/a -530.61K
Change in Working Capital
-112.4K 605.21K 543.6K -1.18M
Operating Cash Flow
-11.25M -8.06M -9.61M -8.72M
Capital Expenditures
-3.24K -2.78K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-3.24K -2.78K n/a n/a
Debt Repayment
-5.2K n/a n/a n/a
Common Stock Repurchased
-15.9K n/a -388.84K -64.4K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-8.56K -52.75K -88.84K -186.49K
Financial Cash Flow
7.73M 6.27M -388.84K 9.8M
Net Cash Flow
-3.51M -1.8M -9.99M 1.08M
Free Cash Flow
-11.25M -8.07M -9.61M -8.72M